Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.745
-0.035 (-1.97%)
May 19, 2026, 11:34 AM EDT - Market open
Stereotaxis Revenue
Stereotaxis had revenue of $6.29M in the quarter ending March 31, 2026, a decrease of -15.81%. This brings the company's revenue in the last twelve months to $31.20M, up 13.40% year-over-year. In the year 2025, Stereotaxis had annual revenue of $32.38M with 20.28% growth.
Revenue (ttm)
$31.20M
Revenue Growth
+13.40%
P/S Ratio
5.58
Revenue / Employee
$238,137
Employees
131
Market Cap
170.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.38M | 5.46M | 20.28% |
| Dec 31, 2024 | 26.92M | 147.00K | 0.55% |
| Dec 31, 2023 | 26.77M | -1.38M | -4.89% |
| Dec 31, 2022 | 28.15M | -6.87M | -19.63% |
| Dec 31, 2021 | 35.02M | 8.39M | 31.51% |
| Dec 31, 2020 | 26.63M | -2.27M | -7.86% |
| Dec 31, 2019 | 28.90M | -444.00K | -1.51% |
| Dec 31, 2018 | 29.35M | -1.80M | -5.77% |
| Dec 31, 2017 | 31.14M | -1.02M | -3.17% |
| Dec 31, 2016 | 32.16M | -5.51M | -14.63% |
| Dec 31, 2015 | 37.67M | 2.66M | 7.61% |
| Dec 31, 2014 | 35.01M | -3.02M | -7.94% |
| Dec 31, 2013 | 38.03M | -8.53M | -18.32% |
| Dec 31, 2012 | 46.56M | 4.58M | 10.90% |
| Dec 31, 2011 | 41.99M | -12.06M | -22.32% |
| Dec 31, 2010 | 54.05M | 2.90M | 5.67% |
| Dec 31, 2009 | 51.15M | 10.78M | 26.72% |
| Dec 31, 2008 | 40.37M | 1.07M | 2.71% |
| Dec 31, 2007 | 39.30M | 12.11M | 44.52% |
| Dec 31, 2006 | 27.19M | 12.17M | 80.96% |
| Dec 31, 2005 | 15.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Embecta | 1.04B |
| AngioDynamics | 313.73M |
| OraSure Technologies | 113.02M |
| Sanara MedTech | 107.48M |
| Pro-Dex | 74.64M |
| KORU Medical Systems | 43.26M |
| Utah Medical Products | 37.53M |
| Nyxoah | 17.67M |
STXS News
- 6 days ago - Stereotaxis price target lowered to $3.50 from $4 at Piper Sandler - TheFly
- 6 days ago - Stereotaxis Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Stereotaxis Earnings release: Q1 2026 - Filings
- 6 days ago - Stereotaxis Quarterly report: Q1 2026 - Filings
- 6 days ago - Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates - GlobeNewsWire
- 27 days ago - Stereotaxis Announces First MAGiC Procedures in the United States - GlobeNewsWire
- 4 weeks ago - Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 4 weeks ago - Stereotaxis Transcript: M&A announcement - Transcripts